December 31st 2024, 8:00pm
In patients with triple-negative breast cancer, ctDNA was most commonly identified within six months after treatment, reflecting the disease’s typical pattern of early recurrence.
December 26th 2024, 4:00pm
CURE® highlights some of the top stories from SABCS, including those focused on older and younger patients with breast cancer, in addition to treatment strategies.
December 19th 2024, 10:00pm
Treatment with Enhertu showed favorable outcomes regarding health-related quality of life in patients with HER2-positive breast cancer, regardless of brain metastases.
December 19th 2024, 8:00pm
Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer.
December 17th 2024, 10:00pm
Younger patients with breast cancer and the BRCA gene showed improved survival after undergoing risk-reducing mastectomy and/or risk-reducing salpingo-oophorectomy.
December 16th 2024, 2:00pm
Presurgical camrelizumab plus chemotherapy significantly improved responses versus chemotherapy alone in early or locally advanced TNBC.
December 13th 2024, 9:37pm
Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of complete tumor removal.
December 13th 2024, 3:00pm
Patients with high-risk, HR-positive, HER2-negative breast cancer treated with HER3-DXd with or without Femara (letrozole) experienced fewer side effects than with chemotherapy.
December 13th 2024, 2:00pm
Several biomarkers may predict improved treatment responses and outcomes in patients with triple-negative breast cancer.
December 12th 2024, 10:00pm
Radiation therapy resulted in improved quality of life and fewer side effects for older patients with stage 1 luminal-like breast cancer than endocrine therapy.
An Expert Offers Advice and Resources for Navigating Rare Lymphoma
Celebrating an Expert at Emotional Support
Dr. Eng Breaks Down Braftovi Plus Erbitux FDA Approval in BRAF+ mCRC
A Healer’s Touch During My Experience With Cancer Care